AI CEOs Call for Congressional Action on Bioweapon Risks

The CEOs of OpenAI, Anthropic, and Microsoft AI have united to warn Congress about the growing risks posed by advancements in artificial intelligence. In a joint letter, Dario Amodei, Sam Altman, and Mustafa Suleyman urged lawmakers to implement stricter safeguards on the buying and selling of synthetic DNA and RNA, materials that could be exploited to create bioweapons with the help of AI.

Industry-Wide Call for Regulation

The letter, organized by the Foundation for American Innovation and the Institute for Progress, was co-signed by dozens of experts in life sciences and national security. Notably, companies like Twist Bioscience and Ansa Biotechnologies, which manufacture synthetic materials, also endorsed the plea for regulation. The CEOs emphasized that while AI offers significant benefits to science and medicine, it also lowers the barriers for malicious actors to develop dangerous biological agents.

"AI systems are improving rapidly, and alongside incredible benefits to science and medicine, there is a real possibility that the knowledge barriers which have historically prevented bad actors from obtaining biological weapons will meaningfully erode," the letter stated.

Proposed Safeguards

The letter calls for Congress to mandate comprehensive screening of companies selling synthetic DNA and RNA, requiring them to maintain detailed records of orders and materials sold. This would aid in biosecurity investigations and help prevent misuse. Currently, some companies voluntarily screen orders, but the CEOs argue that industry-wide legal requirements are necessary to address the growing threat.

AI's Global Reach Amplifies Risks

The warning comes as AI technologies spread rapidly across the globe. A Stanford University study found that generative AI tools reached 53% of the world’s population in just three years, faster than both PCs and the internet. Publicly available AI models have already been shown to provide information on creating and disseminating biological weapons.

While bioweapons account for a small fraction of historical terrorist attacks, their potential for mass harm remains a significant concern. The Biological Weapons Anti-Terrorism Act of 1989 and subsequent legislation like the PATRIOT Act have aimed to curb these threats, but the integration of AI into the equation demands new safeguards.